Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rebuck, J. A.
Right arrow Articles by Rupp, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rebuck, J. A.
Right arrow Articles by Rupp, M. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 46, 461-464
© 2000 The British Society for Antimicrobial Chemotherapy

Brief reports

In vitro activities of parenteral ß-lactam antimicrobials against TEM-10-, TEM-26- and SHV-5-derived extended-spectrum ß-lactamases expressed in an isogenic Escherichia coli host

Jill A. Rebucka, Keith M. Olsena,*, Paul D. Feyb, Kimberly L. Bergmana and Mark E. Ruppb

a Department of Pharmacy Practice and b Department of Internal Medicine, University of Nebraska Medical Center, 986045 Nebraska Medical Center, Omaha, NE 68198-6045, USA

The in vitro activities were determined and time–kill studies of cefepime, imipenem–cilastatin, meropenem and piperacillin–tazobactam were performed against SHVand TEM-derived extended-spectrum ß-lactamases (ESBLs). Sequence-confirmed SHV-5, TEM-10 and TEM-26 ß-lactamases were transferred into Escherichia coli C600N by conjugation. Imipenem and meropenem were more active (MIC range 0.0625–0.25 mg/L) than cefepime (MIC range 2–8 mg/L) and piperacillin–tazobactam (MIC range 8–32 mg/L). Regrowth of strains expressing TEM-10 and TEM-26 was noted at all cefepime and piperacillin–tazobactam concentrations studied. Imipenem–cilastatin and meropenem demonstrated rapid, sustained bactericidal activity uninfluenced by the type of ESBL expressed.

* Corresponding author. Tel: +1-402-559-9016; Fax: +1-402-559-5673; E-mail: kolsen{at}unmc.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 GeneticsHome page
M. Barlow and B. G. Hall
Experimental Prediction of the Natural Evolution of Antibiotic Resistance
Genetics, April 1, 2003; 163(4): 1237 - 1241.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
M. Barlow and B. G. Hall
Predicting Evolutionary Potential: In Vitro Evolution Accurately Reproduces Natural Evolution of the TEM {beta}-Lactamase
Genetics, March 1, 2002; 160(3): 823 - 832.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.